Abstract-Reaction 1H-indole-3-carboxaldhyde 1 with thiosemicarbazide derivatives to give thiosemicarbazone derivatives 2a,b. Cyclization of thiosemicarbazone 2a with HCl, Ac 2 O, phenacyl bromides and chloroacetic acid afforded the corresponding 1,2,4-triazole-3-thiol derivative 3, diacetyl derivative 4 and 1,3-thiazole derivative 5 and 1,3-thiazolidin-4-ones derivative 6 respectively. Compound 6 undergoes a series of heterocyclization reactions to give new heterocyclic compounds. The structure of the newly synthesized compounds had been confirmed by elemental analysis and spectra data. The some newly synthesized compounds were evaluated for in vitro cytotoxic activity against three human cancer cell lines, including human liver cancer (HepG2), human colon cancer (HT-29) and human breast cancer (MCF-7) using MTT assay. : thiosemicarbazone, 1.3-thiazole,1, 3 thia-zoldinone, pyrazolo[3,4-d] O, phenacyl bromides and chloroacetic acid afforded the corresponding 1,2,4-triazole-3-thiol derivative 3, diacetyl derivative 4 and 1,3-thiazole derivative 5 and 1,3-thiazolidin-4-ones derivative 6 respectively. Compound 6 undergoes a series of heterocyclization reactions to give new heterocyclic compounds. The structure of the newly synthesized compounds had been confirmed by elemental analysis and spectra data. The some newly synthesized compounds were evaluated for in vitro cytotoxic activity against three human cancer cell lines, including human liver cancer (HepG2), human colon cancer (HT-29) and human breast cancer (MCF-7) using MTT assay.
I. Introduction
hiosemicarbazones has been used as intermediated for the preparation of many heterocyclic compounds. In the literature many researchers have reported the S/N regioselective nucleophilic completion in the synthesis of heterocyclic compounds by intramolecular cyclization reactions. Changes in reaction conditions can induce S-attack or N-attack to eventually afforded different cyclic products from a singlet starting material. Moreover, thiosemicarbazones bearing an aromatic heterocyclic moiety seem to possess enhanced biological activities 1, 2 . On other hand, indoles major importance due to its therapeutic and pharmacological activities [3] [4] [5] [6] [7] .
In view of the above and in continuation of our studies on the synthesis of heterocyclic compounds exhibiting biological activity, we report here reaction1H-indol-3-carboxaldehyde with thiosemicarbazide derivatives to afforded the corresponding thiosemicarbazones derivatives, then cyclization by different reagents and different conditions to give some novel heterocyclic compounds bearing indole moiety.
II. Result and Discussion

a) Chemistry
The synthetic procedures adopted to obtain the target compounds are outlined in Schemes 1-3. The key intermediate 1-[1H-indol-3-ylmethylene] thiosemicarbazone derivatives 2a,b were prepared by reaction1H-indole-3-carboxaldehyde 1 with thiosemicarbazide derivatives such as 4-(4-methylphenyl) thiosemicarbazide or 4-(4-phenyl-1,3-thiazol-2-yl) thiosemicarbazide in refluxing ethanol containing acetic acid 8 (Scheme 1). The structure of compound 2a,b were based on analytical and spectral data. The 1H-NMR spectra of 2a displayed D 2 O-exchangeable signals at δ 10.01,δ 11.46,δ 11.99 ppm of three NH protons and singlet signal at δ 2.32 ppm for CH 3 proton.
Cyclizing of thiosemicarbazone derivative 2a depended on cyclizing agent and conditions of reaction. Thus, Thiosemicarbazones derivative 2a which may undergo to ring closure by acid medium 9 afforded 5-[1H-indol-3-yl]-4H-1,2,4-triazole-3-thiol derivative 3 (Scheme 1).1H-NMR spectra of 3 displayed D 2 Oexchangeable signals at δ 4.33 ppm and δ 12.05 ppm of SH and NH protons respectively. While, heterocyclization of thiosemicarbazone derivative 2a in the presence of acetic anhydride gives N-[4-acetyl-5-(1H-indol-3-yl)-1,3,4-thiadiazol-2-yl] acetamide 4 (Scheme 1 ). Suggest that the mechanism of the reaction compound 2a with acetic anhydride follows Figure 1 . Reaction compound 2a with acetic anhydride, the resonance effects between NH and the phenyl group may reduce the nucleophilicity of NH and the steric effect of phenyl group on the NH retards nucleophilic substitution with acetic anhydride.
Therefore, the initial monoacetyl-substituted products are gradually converted to diacetyl substituted thiadiazoline 10 4.1H-NMR spectrum of compound 4 showed a signal at δ 2.16, δ 2.19, δ 2.26 ppm corresponding to three CH 3 groups and multiplet signal at δ 6.93-7.28 ppm for the aromatic protons and CH-5 of1,3,4-thiadiazoline ring. The mass spectrum of compound 4 showed the molecular ion peak at m/z 547 corresponding to the molecular formula C 27 H 23 Br N 4 O 2 S. Furthermore, treatment of thiosemicarbazone derivative 2a with phenacyl bromides in boiling ethanol in the presence of anhydrous sodium acetate 11 yielded the corresponding 3-[1,3-thiazol-2(3H)-ylidene]hydrazonomethyl-1H-indole derivative 5.1H-NMR spectrum of 5 showed a signal at δ 6.58 ppm corresponding to CH-5 of thiazole ring and signal at δ 8.30 ppm for an N=CH proton .The mass spectrum of compound 5 showed the molecular ion peak at m/z 563 corresponding to the molecular formula C 31 H 23 BrN 4 S. Refluxing thiosemicarbazone derivative 2a with chloroacetic acid in the presence of anhydrous sodium acetate in glacial acetic acid 12 afforded 1,3-thiazolidin-4-one derivative 6 (Scheme 1). IR spectra of 6 showed the disappearance of NH bands of substituted thiosemicarbazone moiety and the presence of a new band at 1703 cm −1 attributed to a carbonyl group of thiazolidin-4-one. The 1H-NMR spectra of 6 showed a new signal at 4.09 ppm attributed to CH 2 protone of thiazolidinone ring . 13 C NMR spectra of 6 showed signals at δ 20.65, 32.16, 152, 162 and 172 ppm to CH 3 , CH 2 , N=CH, C=N and C=O respectively.
Condensation1,3-thiazolidin-4-one derivative 6 with benzaldehyde in the presence of freshly fused sodium acetate in boiling glacial acetic acid yielded the corresponding arylidene derivatives 13 7 (Scheme 2). The analytical and spectral data of compound 7 was consistent with the proposed structure.Thus,1H-NMR spectrum of compound 7 showed absence of thiazolomethylene protons, and showed a multiplet signal at δ 7.25-7.32 for the aromatic protons and olefinic CH= proton. 13 C NMR spectra of 7 showed signals at δ 20.68, 142, 153, 156 and 165 ppm to CH 3 ,C=CH, N=CH, N=C and C=O respectively.
Compound 7 was used as starting material for further syntheses of other heterocyclic compounds. Thus, reaction compound 7 with phenyl hydrazine Moreover, chloroformylation of1,3-thiazolidin-4-one derivative 6 using Vilsmeier-Haack reagent to 4-chloro-1,3-thiazole-5-carboxaldehyde 10.The most probable reaction involves initial formation of intermediate A-C that underwent further chlorination and hydrolysis to yield final products 16 10( Figure 2 ). The IR spectrum of compound 10 showed bands at 1675 cm -1 due to C=O group. The 1H-NHR revealed a new signal at δ 9.95 ppm assigned to CHO proton and disappearance signal at δ 4.09 ppm attributed to CH 2 thiazolidinone. 13 C-NMR spectra of 7 showed new signal at δ135.89 ppm assigned for C-Cl group. Reaction 4-chloro-1,3-thiazole-5-carboxaldehyde 10 with hydrazine hydrate 17 afforded the corresponding pyrazolo [3,4- The active methylene in 1,3-thiazolidin-4-one derivative 6 was allowed to react with phenyl isothiocyanate in dry N, N-dimethylformamide (DMF ) containing catalytic amount of potassium hydroxide to give the non-isolable potassium salt 14 and then ethylchloroacetate 19 was added afforded 2'-[1H-indol-3-ylmethylenehydrazono]-2,5'-bi-1,3-thiazolidin-2'-ylidene-4,4'-dione 16 (Scheme 3). Probably, the reaction mechanism is assumed to proceed via S-alkylation to give the intermediate 15 which was cyclized to 16. Elemental analyses and spectral data were in favor of these proposed 1,3-thiazolidinone structures. The 1H-NMR spectrum of compound 16 showed singlet signal at 4.09 ppm corresponding to CH 2 protons of the thiazolidinone ring. 
b) In Vitro Cytotoxicity Activity
The newly synthesized compounds 1, 2a, 6 and 11 were evaluated for their in vitro cytotoxic effects against human liver cancer (Hep G2),human colon cancer (HT-29) and human breast cancer (MCF-7) cell lines by the standard MTT (3-(4,5-l-2-yl)-dimethylthiazo-2,5-diphenyl tetrazolium bromide) assay21,22.
The method is based on the ability of a mitochondrial dehydrogenase from viable cells to cleave the tetrazolium rings of the pale yellow MTT and form purple formazan crystals which are impermeable to cell membranes (Scheme 4). The crystals can be solubilized by detergents. The number of living cells is directly proportional to the level of formed formazan which can be quantified photometrically. When the amount of purple formazan produced by cells treated with an agent is compared with the amount of formazan produced by untreated control cells, the effectiveness of the agent in causing death of cells can be deduced (see Figure 3) .
MTT assay to determine the drug concentration required to inhibit the growth of human cancer cells by 50% (IC 50 ).The results of the MTT assay percentage viability cell and IC 50 values are shown in Tables 1 and 2 and Figs.4 -7.
Scheme 4 : Principle of MTT assay
In order to investigate the structure activity relationship the intact indole ring was reserved for a different substituted to position 3. The obtained results from value of IC 50 ( IC 50 : Concentration that causes a 50 % reduction of the cell growth. 
III. Conclusion
In this work, variety of heterocyclic systems have been synthesized from the thiosemicarbazone derivatives .The new synthesis compounds 1,2a,6 and 11 have been evaluated for the vitro cytotoxic activity against human liver cancer (HepG2), human colon cancer l (HT-29),and human breast cancer (MCF-7) cell lines activity using MTT assay, compound 11 showed best cytotoxic activity against all the three cancer cell lines due to the presence of pyrazolo [3,4-d] [1, 3] thiazol group at position-3 of indole ring. Compounds 1 also showed higher cytotoxic activities against the human liver cancer (Hep G2) and human breast cancer ( MCF-7) cell line due to the presence of CHO group at position-3 of indole ring, compound 2a also showed higher cytotoxic activities against the human liver cancer (Hep G2) cell line due to the presence of thiosemicarbazone group at position-3 of indole ring and compound 6 also showed higher cytotoxic activities against the human breast cancer (MCF-7) cell line due to the presence of 1,3-thiazolidine ring at position-3 of indole ring.Hence it can be suggested that compound 1,2a,6 and 11 could be used as leads in the design and development of new anticancer drugs.
IV. Experimental a) Chemistry
Melting points were measured on a Gallenkamp apparatus and are uncorrected. IR spectra were recorded on Shimadzu FT-IR 8101 PC infrared spectrophotometer (υ max in cm -1 ). The 1H-NMR and 13 C NMR spectra were determined in DMSO-d6 at 300 MHz on a Varian Mercury VXR-300, NMR spectrometer using TMS as an internal standard. Mass spectra were measured on a GCMS-QP1000 EX spectrometer at 70 Ev. Elemental analyses were carried out at the Microanalytical center of Cairo University and main defence chemical laboratory.
i. General procedure for the preparation of thiosemicarbazones 2a,b
An equimolecular mixture of 2-(4-bromophenyl)-1H-indole-3-carboxaldehyde 1 and the selected thiosmi-carbazide such as 4-(4-methylphenyl) thiosemicarbazide or 4-(4-phenyl-1,3-thiazol-2-yl) thiosemicarbazide (0.01 mol) were refluxed in absolute ethanol (20 ml) in the presence of 2-3 drops of glacial acetic acid for the 3h.The reaction mixture was cooled to room temperature and separated product was filtered off, washed with cold water, dried and recrystallized from the appropriate solvent to give 2a,b .
ii. iii. iv.
1-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-N-(4 methylphenyl)thiosemicarbazone 2a
1-[2-(4-Bromophenyl)-1H-indol-3-ylmethylene]-N-(4-phenyl-1,3-thiazol-2-yl)-thiosemicarbazone 2b
5-[2-(4-Bromophenyl)-1H-indol-3-yl]-4-(4-methyl phenyl)-4H-1,2,4-triazole-3-thiol 3
A solution of thiosemicarbazone derivative 2a (0.01 mol) in absolute ethanol (15 ml) containing few drops of HCl was refluxed for 2 h. After cooling and dilution with water, the solid formed were filtered off, washed with water, air dried and recrystallized from ethanol to give 3 as green powder. 
v. N-[4-acetyl-5-(2-(4-bromophenyl)-1H-indol-3-yl)-4,5-dihydro-1,3,4-thiadiazol-2-yl]-N-(4-methyl-phenyl) acetamide 4
A solution of the thiosemicarbazone derivative 2a in acetic anhydride (12 ml) was heated under reflux for 5 h. with continuous stirring and then allowed to attain room temperature. The reaction mixture was slowly added to 400 ml of ice-cooled water and then stirred at room temperature for 1h. The separated product was collected by filtration, washed with water, dried, and recrystallized from ethanol and DMF (2:1) 
vi. 2-(4-Bromophenyl)-3-[3-(4-methylphenyl)-4-phenyl-1,3-thiazol-2(3H)-ylidene]hydrazonomethyl-1H-indole 5
To a solution of thiosemicarbazone derivative 2a (0.01 mol) in absolute ethanol (20 ml) were added equimolar amounts of the phenacyl bromides and anhydrous sodium acetate. The reaction mixture was heated under reflux for 6 h with continuous stirring, then partially concentrated under reduced pressure and left to cool. The separated solid product was filtered off and recrystallized from ethanol to give 5 as yellow solid . 
vii. 2-(4-Bromophenyl)-3-[3-(4-methylphenyl)-4-oxo-1,3-thia-zolidin-2-ylidene]hydrazonomethyl-1H-indole 6
A mixture of thiosemicarbazone derivative 2a (0.01 mol), chloroacetic acid ( 0.01 mol), and anhydrous sodium acetate ( 0.01 mol) in glacial acetic acid (20 ml ) was heated under reflux for 8 h with continuous stirring. The reaction mixture was left to cool and poured into ice-cold water, and the separated solid was filtered off, washed with water, dried, and recrystallized from DMF to give 6 as yellow powder. 
viii. 2-(4-Bromophenyl )-3-[5-benzylidene-3-(4-methylphenyl)-4-oxo-1,3-thiazolidin-2-ylidene]hydrazonomethyl-1H-indole 7
To a solution of compound 6 (0.01 mol) and anhydrous sodium acetate (0.015 mol) in glacial acetic acid (10 ml) was added the benzaldehyde (0.01 mol). The mixture was heated under reflux for 6 h with continuous stirring. The reaction mixture was left to cool and poured onto crushed ice with stirring. The separated solid was filtered off, washed with water, dried, and recrystallized from ethanol and DMF 2-(4-Bromophenyl)-3-[6-(4-methylphenyl)-2,3-di- 
phenyl-2,3,3a,6-tetrahydro-5H-pyrazolo[3,4-d]1,3-thiazol-5 ylidene]hydrazonomethyl-1H-indole 8
A mixture of compound 7 (0.01mol) and phenyl hydrazine (0.01 mol) was refluxed in ethanol (50 ml) in present of few drops of acetic acid for 4 h. The reaction mixture was cooled, and the solid separated was filtered off, washed with water and recrystallized from aqueous ethanol to give compound 8 as orange powder. Yield 55 % yield; m.p.102-104°C. FT-IR (KBr, υ max / cm x.
2-(4-Bromophenyl)-3-[3-phenyl-6-(4-methylphenyl)-3,3a-dihydro-1,3-thiazolo[4,5-c]isoxazol-5-ylidene] hydrazono-methyl-1H-indole 9
A mixture of compound 7 (0.01 mol), hydroxylamine hydrochloride (0.012 mol), sodium acetate (0.012 mol) was refluxed in ethanol (30 ml) in present of few drops of acetic acid for 10 h., and kept overnight. Excess of solvent was distilled off under reduced pressure and the remainder was then poured into water. The solid obtained was recrystallized from ethanol to give 9 as white powder. 
-[2-(4-Bromophenyl)-1H-indol -3-ylmethylidenehydrazono]-4-chloro-3-(4-methylphenyl)-2,3 dihydro-1,3-thiazole-5-carboxaldehyde 10
To the Vilsmeier-Haack complex prepared from DMF (10 ml) and POCl 3 ( 0.02 mole) at 0 o C was added the 1,3-thiazolidin-4-one derivative 6 ( 0.004 mol) and the reaction mixture was stirred at 60-65 o C for 4 hr. The reaction mixture was kept overnight and it was then slowly added to crushed ice. The product separated on neutralization with NaHCO 3 was filtered and recrystallized from ethanol to give 10 as yellow powder. 
xiii. N'-{2-[2-(4-Bromophenyl)-1H-indol-3-ylmethylenehydra-zono]-4-chloro-3-(4-methylphenyl)-2,3-dihydro-1,3-thiazol-5-ylmethylene}-2-cyanoacetohydrazide 12
An equimolar mixture of 10 (0.02 mol) and cyanoacetic acid hydrazide (0.02 mol) in absolute ethanol (30 ml) was heated under reflux for 2 h. The precipitate formed after cooling was filtered off, washed with cold ethanol, dried and recrystallized from xylene to give 12 as orange powder. To a stirred suspension of finely powdered potassium hydroxide (0.02 mol) in dry DMF (20 ml), 1,3-thiazolidin-4-one 6 ( 0.01 mol) was added. The resulted mixture was cooled at 10 o C in an ice bath; then (0.01mol) carbon disulfide was added slowly over the course of 10 min. After complete addition, stirring of the reaction mixture was continued for 6 h .Then phenacyl bromide ( 0.01mol) was added to the mixture and stirring continued for 3 h, then the mixture was poured into crushed ice and HCl, the resulting precipitate was filtrated off, dried, and recrystallized from xylene to give 18 as red powder. Yield, 60 % ; m.p. 
b) In Vitro Cytotoxic Screening (MTT assay)
In vitro cytotoxicity of newly synthesized compounds 1, 2a, 6 and 11 were evaluated against human liver cancer cell (HepG2), human colon cancer cell (HT 29) and human breast cancer cell ( MCF-7 ) cell line using a standard MTT assay.
The monolayer cells were detached with trypsinethylenediaminetetraacetic acid (EDTA) to make singlet cell suspensions and viable cells were counted using a hemocytometer, then diluted with the fetal bovine serum (FBS) medium with 5% FBS to give final density of 2 × 105 cells / ml. One hundred microlitres per well of cell suspension were seeded into 96-well plates at plating density of 10,000 cells/well and incubated to allow for cell attachment at 37 0C, 5 % CO2 , 95 % air and 100% rela-tive humidity.
The synthesized samples were dissolved in 1 ml dimethylsulfoxide (DMSO) and further diluted in serum free medium to produce six concentration starting from 1mg/ml to 10-6. About 500-10,000 cells in 200 µl media per well were incubated at 37 0C and 5 % CO2 overnight to allow the cells to attach to the wells. 100 µl, from each dilution of tested samples, was added to each well, mix by shaking at 150 rpm for 5 minutes, incubate at 37 0C and 5 % CO2 for 48 hr. 20 μl of MTT (5mg/ml ) in phosphate buffered saline ( PBS ) was added to each well plate and mix by shaking at 150 rpm for 5 minutes and incubate at 37 0C and 5 % CO2 for 5 hr to allow the MTT to be metabolized. The medium with MTT was then flicked off and the formed formazan crystals (MTT metabolic product) were solubilized in 200 μl of DMSO and then absorbance was measured at 560 nm using micro plate reader 23 . Viability of treated cells was calculated in reference to the untreated control cells by using the fol-lowing formula:
Cell viability (%) = [100 × (Sample Abs)/(Control Abs)]. 
